Effect of dietary Schizochytrium microalga oil and fish oil on plasma cholesterol level in rats
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25040911
DOI
10.1111/jpn.12221
Knihovny.cz E-zdroje
- Klíčová slova
- Insig-1, Schizochytrium, cholesterol, docosahexaenoic acid, fish oil, nSREBP-2,
- MeSH
- cholesterol krev MeSH
- dieta MeSH
- játra chemie metabolismus MeSH
- krmivo pro zvířata analýza MeSH
- krysa rodu Rattus MeSH
- mikrořasy chemie MeSH
- náhodné rozdělení MeSH
- nenasycené mastné kyseliny chemie metabolismus MeSH
- oleje rostlin chemie farmakologie MeSH
- potkani Wistar MeSH
- protein SREBP2 genetika metabolismus MeSH
- regulace genové exprese účinky léků MeSH
- rybí oleje chemie farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- cholesterol MeSH
- nenasycené mastné kyseliny MeSH
- oleje rostlin MeSH
- protein SREBP2 MeSH
- rybí oleje MeSH
The purpose of the study was to test the hypothesis that the dietary oils with different content of n-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) affect plasma lipid level in rats in a different degree. The diets with 6% of fish oil (FO) and Schizochytrium microalga oil (SchO; EPA+DHA content in the diets 9.5 + 12.3 and 2.6 + 29.5% of the sum of total fatty acids, respectively) were used; the diet with 6% of safflower oil (high content of n-6 PUFA linoleic acid, 65.5%; EPA+DHA content 0.7 + 0.9%) was used as a control. The difference between FO and SchO was established only in the case of plasma triacylglycerol (TAG) level: plasma TAG of the FO-fed rats did not differ from the control rats (p > 0.05), while SchO decreased (p < 0.05) plasma TAG to 46% of the control. On the other hand, FO and SchO decreased (p < 0.05) total plasma cholesterol (TC) in rats in the same extent, to 73% of the control. Regarding the underlying mechanisms for the TC decrease, both SchO and FO up-regulated hepatic Insig-1 gene (181 and 133% of the control; p < 0.05), which tended (p = 0.15 and p = 0.19 respectively) to decrease the amount of hepatic nSREBP-2 protein (61 and 66% of the control). However, neither SchO nor FO influenced hepatic 3-hydroxy-3-methyl-glutaryl-CoA reductase gene expression (p > 0.05); SchO (but not FO) increased (p < 0.05) low-density lipoprotein receptor mRNA in the liver. It was concluded that the decrease of total plasma cholesterol might be caused by an increased cholesterol uptake from plasma into the cells (in the case of SchO), but also by other (in the present study not tested) mechanisms.
Citace poskytuje Crossref.org